In 2004, Dan Gibson was drawn to a project at the J. Craig Venter Institute: to build a synthetic cell from scratch. Within days, he was on a path to creating synthetic life alongside genomics pioneers. But to build a whole genome from scratch, Gibson had to first invent new methods to assemble DNA. One method, dubbed the "Gibson Assembly," became a game changer, and a series of firsts followed: first synthetic bacterial genome, first synthetic cell, first minimal cell. Today, these discoveries inform the design of synthetic DNA used for new medicines.

Gibson's teams at SGI and SGI-DNA recently introduced the world's first biologic teleporter, called the Digital-to-Biological Converter (DBC), which turns digital code into functional biologics in the form of DNA, RNA and proteins without human intervention. Imagine a future where digital code is emailed to DBCs at hospitals around the world to deliver personalized medicine at a patient's bedside.